SciClone Pharmaceuticals (Holdings) Limited dated February 19, 2021 in relation to, among other things, the appointment of Ms. Pan Rongrong (Ms. Pan) and Ms. Chan Sin Man Nico (Ms. Chan) as joint company secretaries of the Company and the waiver granted to the company by The Stock Exchange of Hong Kong Limited from strict compliance with Rules 3.28 and 8.17 of the Rules Governing the Listing of Securities on the Stock Exchange. The Company hereby announces that the Company has recently obtained a confirmation from the Stock Exchange that Ms. Pan has met the qualifications to act as company secretary of the Company as required under the Listing Rules such that a further waiver will not be necessary. Accordingly, Ms. Pan will act as the company secretary of the Company.

Ms. Chan has resigned as the joint company secretary with effect from March 28, 2024.